Asthma and COPD proteomics: current approaches and future directions (Q38287694)

1 September 2017

1 reference

title

Asthma and COPD proteomics: current approaches and future directions (English)

1 reference

chronic obstructive pulmonary disease

1 September 2017

0 references

1 reference

Rocco Savino

4

0 references

author name string

Rosa Terracciano

series ordinal

1

1 reference

PubMed ID

25504544

1 September 2017

Girolamo Pelaia

series ordinal

2

1 reference

PubMed ID

25504544

1 September 2017

Mariaimmacolata Preianò

series ordinal

3

1 reference

1 September 2017

23 January 2015

1 reference

Proteomics - Clinical Applications

1 September 2017

1 reference

1 September 2017

9

1 reference

1 September 2017

1-2

1 reference

1 September 2017

203-220

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

1 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Epidemiology of asthma: prevalence and burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Complex phenotypes in asthma: current definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Treating systemic effects of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Application of proteomics and peptidomics to COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics in pulmonary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

The potential of biologics for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

New anti-inflammatory targets for chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Induced sputum: a window to lung pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics-based biomarkers in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Induced sputum proteome in healthy subjects and asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Sputum proteomics in inflammatory and suppurative respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Shotgun proteomic analysis of human-induced sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Protein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic analysis of human epithelial lining fluid by microfluidics-based nanoLC-MS/MS: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Susceptibility to COPD: differential proteomic profiling after acute smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Safety of and cellular response to segmental bronchoprovocation in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Disease surveillance using bronchoalveolar lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic analysis of undiluted lung epithelial lining fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteome analysis of bronchoalveolar lavage in lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics of bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics and the lung: Analysis of bronchoalveolar lavage fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Allergen-induced airway remodeling is impaired in galectin-3-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Spectral index for assessment of differential protein expression in shotgun proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Characterization of the phosphoproteome in human bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Identification of proteomic signatures associated with lung cancer and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Mass spectrometry in high-throughput proteomics: ready for the big time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Accurate quantitation of protein expression and site-specific phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Collection and analysis of exhaled breath condensate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic analysis of the asthmatic airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

A new approach to study exhaled proteins as potential biomarkers for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

The proteomics big challenge for biomarkers and new drug-targets discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic study of plasma proteins in pregnant women with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Alpha-1-antitrypsin and complement component C7 are involved in asthma exacerbation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Plasma protein profiles in early asthmatic responses to inhalation allergen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Application of proteomics in asthma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Improved image analysis workflow for 2-D gels enables large-scale 2-D gel-based proteomics studies--COPD biomarker discovery study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Two-dimensional gel electrophoresis of nasal and bronchoalveolar lavage fluids after occupational exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Protein profiling as a diagnostic tool in clinical chemistry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Reproducibility in protein profiling by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Biomarkers in chronic obstructive pulmonary disease: confusing or useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

An integrative systems biology approach to understanding pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

From proteomics to prescription-the search for COPD biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

Proteomics of Epithelial Lining Fluid Obtained by Bronchoscopic Microprobe Sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201400099

21 January 2018

Identifiers

DOI

10.1002/PRCA.201400099

1 reference

1 September 2017

1 reference

PubMed ID

25504544